| Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM JG Viniegra, N Martínez, P Modirassari, JH Losa, CP Cobo, VJSA Lobo, ... Journal of Biological Chemistry 280 (6), 4029-4036, 2005 | 350 | 2005 |
| Regulation of the transcriptional activity of c-Fos by ERK: a novel role for the prolyl isomerase PIN1 P Monje, J Hernández-Losa, RJ Lyons, MD Castellone, JS Gutkind Journal of Biological Chemistry 280 (42), 35081-35084, 2005 | 333 | 2005 |
| Clinical implications of intratumor heterogeneity: challenges and opportunities S Ramón y Cajal, M Sesé, C Capdevila, T Aasen, L De Mattos-Arruda, ... Journal of Molecular Medicine 98, 161-177, 2020 | 305 | 2020 |
| Role of the p38 MAPK pathway in cisplatin-based therapy JH Losa, CP Cobo, JG Viniegra, VJSA Lobo, R Sanchez-Prieto Oncogene 22 (26), 3998-4006, 2003 | 228 | 2003 |
| Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project FH Blackhall, S Peters, L Bubendorf, U Dafni, KM Kerr, H Hager, ... Journal of clinical oncology 32 (25), 2780-2787, 2014 | 201 | 2014 |
| miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9 A Feliciano, J Castellvi, A Artero-Castro, JA Leal, C Romagosa, ... PloS one 8 (10), e76247, 2013 | 174 | 2013 |
| The voltage-dependent K+ channels Kv1.3 and Kv1.5 in human cancer N Comes, J Bielanska, A Vallejo-Gracia, A Serrano-Albarrás, L Marruecos, ... Frontiers in physiology 4, 283, 2013 | 138 | 2013 |
| Voltage-dependent potassium channels Kv1. 3 and Kv1. 5 in human cancer J Bielanska, J Hernandez-Losa, M Perez-Verdaguer, T Moline, R Somoza, ... Current cancer drug targets 9 (8), 904-914, 2009 | 115 | 2009 |
| RHOA inactivation enhances Wnt signalling and promotes colorectal cancer P Rodrigues, I Macaya, S Bazzocco, R Mazzolini, E Andretta, H Dopeso, ... Nature communications 5 (1), 5458, 2014 | 111 | 2014 |
| S-adenosylhomocysteine hydrolase downregulation contributes to tumorigenesis JF Leal, I Ferrer, C Blanco-Aparicio, J Hernandez-Losa, S Ramon y Cajal, ... Carcinogenesis 29 (11), 2089-2095, 2008 | 111 | 2008 |
| Molecular profiling of patients with colorectal cancer and matched targeted therapy in phase I clinical trials R Dienstmann, D Serpico, J Rodon, C Saura, T Macarulla, E Elez, ... Molecular cancer therapeutics 11 (9), 2062-2071, 2012 | 97 | 2012 |
| miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer A Feliciano, Y Garcia-Mayea, L Jubierre, C Mir, M Hummel, J Castellvi, ... Cell death & disease 8 (10), e3141-e3141, 2017 | 86 | 2017 |
| The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis H Dopeso, S Mateo-Lozano, R Mazzolini, P Rodrigues, L Lagares-Tena, ... Cancer research 69 (18), 7430-7438, 2009 | 86 | 2009 |
| Fluorescence In Situ Hybridization and Immunohistochemistry as Diagnostic Methods for ALK Positive Non-Small Cell Lung Cancer Patients P Martinez, J Hernández-Losa, Ma Ángeles Montero, S Cedrés, ... PloS one 8 (1), e52261, 2013 | 85 | 2013 |
| Targeting the voltage-dependent K+ channels Kv1. 3 and Kv1. 5 as tumor biomarkers for cancer detection and prevention A Felipe, J Bielanska, N Comes, A Vallejo, S Roig, S Ramon y Cajal, ... Current medicinal chemistry 19 (5), 661-674, 2012 | 82 | 2012 |
| Triggering MSR1 promotes JNK‐mediated inflammation in IL‐4‐activated macrophages M Guo, A Härtlova, M Gierliński, A Prescott, J Castellvi, JH Losa, ... The EMBO journal 38 (11), e100299, 2019 | 81 | 2019 |
| Evaluation of NGS and RT-PCR methods for ALK rearrangement in European NSCLC patients: results from the European Thoracic Oncology Platform Lungscape Project I Letovanec, S Finn, P Zygoura, P Smyth, A Soltermann, L Bubendorf, ... Journal of Thoracic Oncology 13 (3), 413-425, 2018 | 75 | 2018 |
| Brush border myosin Ia has tumor suppressor activity in the intestine R Mazzolini, H Dopeso, S Mateo-Lozano, W Chang, P Rodrigues, ... Proceedings of the National Academy of Sciences 109 (5), 1530-1535, 2012 | 72 | 2012 |
| The new antitumor drug ABTL0812 inhibits the Akt/mTORC1 axis by upregulating tribbles-3 pseudokinase T Erazo, M Lorente, A López-Plana, P Muñoz-Guardiola, ... Clinical Cancer Research 22 (10), 2508-2519, 2016 | 70 | 2016 |
| Identification and genotyping of human papillomavirus in a Spanish cohort of penile squamous cell carcinomas: correlation with pathologic subtypes, p16INK4a expression, and … C Ferrándiz-Pulido, E Masferrer, I De Torres, B Lloveras, ... Journal of the American Academy of Dermatology 68 (1), 73-82, 2013 | 70 | 2013 |
